"C\u00EDlem t\u00E9to pr\u00E1ce je podat liter\u00E1rn\u00ED p\u0159ehled sou\u010Dasn\u00FDch poznatk\u016F o problematice infekce Helicobacter pylori u diabetes mellitus. Podle p\u0159ev\u00E1\u017En\u00E9 v\u011Bt\u0161iny autor\u016F se prevalence infekce Helicobacter pylori u diabetik\u016F neli\u0161\u00ED od v\u0161eobecn\u00E9 populace. Infekce Helicobacter pylori nehraje roli v etiopatogeneze diabetu. Pouh\u00FD n\u00E1lez Helicobacter pylori nen\u00ED u diabetu indikac\u00ED k eradika\u010Dn\u00ED terapii. Pokud je protihelikobakterov\u00E1 l\u00E9\u010Dba provedena z jin\u00E9 indikace, je u diabetik\u016F \u00FAsp\u011B\u0161nost eradikace men\u0161\u00ED (ve srovn\u00E1n\u00ED s nediabetiky) a je vy\u0161\u0161\u00ED riziko reinfekce. \u0158ada ot\u00E1zek (zejm\u00E9na dysmotilitn\u00EDch poruch \u017Ealudku a vlivu eradikace Helicobacter pylori na kompenzaci diabetu) z\u016Fst\u00E1v\u00E1 nedo\u0159e\u0161ena." . . "This paper provides a review of current literature on Helicobacter pylori infection in diabetes mellitus. According to majority of studies there is no difference of Helicobacter pylori infection prevalence between diabetes mellitus and general population. There is no role of Helicobacter pylori in etiopathogenesis of diabetes. The only finding of Helicobacter pylori itself has not been an indication for eradication therapy in diabetes. In case of anti-helicobacter therapy (due to another indication) eradication rate is lower in diabetics (compared to non-diabetics) and there is a higher risk of re-infection (compared to general population). Several issues (especially dysmotility disorders of the stomach and influence of Helicobacter pylori eradication for the control of diabetes) remain controversial."@en . "4"^^ . "Clinical importance of Helicobacter pylori infection in patients with diabetes mellitus"@en . "C\u00EDlem t\u00E9to pr\u00E1ce je podat liter\u00E1rn\u00ED p\u0159ehled sou\u010Dasn\u00FDch poznatk\u016F o problematice infekce Helicobacter pylori u diabetes mellitus. Podle p\u0159ev\u00E1\u017En\u00E9 v\u011Bt\u0161iny autor\u016F se prevalence infekce Helicobacter pylori u diabetik\u016F neli\u0161\u00ED od v\u0161eobecn\u00E9 populace. Infekce Helicobacter pylori nehraje roli v etiopatogeneze diabetu. Pouh\u00FD n\u00E1lez Helicobacter pylori nen\u00ED u diabetu indikac\u00ED k eradika\u010Dn\u00ED terapii. Pokud je protihelikobakterov\u00E1 l\u00E9\u010Dba provedena z jin\u00E9 indikace, je u diabetik\u016F \u00FAsp\u011B\u0161nost eradikace men\u0161\u00ED (ve srovn\u00E1n\u00ED s nediabetiky) a je vy\u0161\u0161\u00ED riziko reinfekce. \u0158ada ot\u00E1zek (zejm\u00E9na dysmotilitn\u00EDch poruch \u017Ealudku a vlivu eradikace Helicobacter pylori na kompenzaci diabetu) z\u016Fst\u00E1v\u00E1 nedo\u0159e\u0161ena."@cs . "CZ - \u010Cesk\u00E1 republika" . "Klinick\u00FD v\u00FDznam infekce Helicobacter pylori u nemocn\u00FDch s diabetes mellitus"@cs . . . . "Klinick\u00FD v\u00FDznam infekce Helicobacter pylori u nemocn\u00FDch s diabetes mellitus" . . . "570186" . . "350;353" . "Clinical importance of Helicobacter pylori infection in patients with diabetes mellitus"@en . . . "[6F61716FDC43]" . "Klinick\u00FD v\u00FDznam infekce Helicobacter pylori u nemocn\u00FDch s diabetes mellitus"@cs . . . . "RIV/00216208:11150/04:00004619" . "5" . . "4"^^ . . "Klinick\u00FD v\u00FDznam infekce Helicobacter pylori u nemocn\u00FDch s diabetes mellitus" . "RIV/00216208:11150/04:00004619!RIV08-MSM-11150___" . "1"^^ . "Bure\u0161, Jan" . "50" . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . . "S" . . . "0042-773X" . "11150" . "Clinical; importance; Helicobacter; pylori; infection; patients; diabetes; mellitus"@en . . .